We have been serving businesses which sell to industries since 1990, developing methodologies and tools to structure organisation-level data at scale. Our dedicated focus means that we are better placed than anyone to understand the shape and dynamics of the markets we cover. We provide daily analysis, opportunity identification and commentary on commercial firms, public bodies, industries and geographic markets, all designed to integrate with our clients' core sales and marketing functions. We aim for our analysts to become an extension of our client's business development functions, facilitating better market planning, targeting and client engagement.
| Website | http://www.drugdevelopment-technology.com |
| Revenue | $18.4 million |
| Employees | View employees |
| Address | 441 Lexington Ave Fl 3, New York, New York 10017, US |
| Industry | Manufacturing General, Manufacturing |
| Competitors | BioPharma Dive, DrugDev, Endpoints News, Labiotech.eu, CenterWatch, A WCG Company, PharmaTimes Media Ltd, FierceBiotech, Outsourcing-Pharma, Clinical Trials Arena, Pharmafocus.com +31 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular drugdevelopment-technology.com employee's phone or email?
The drugdevelopment-technology.com annual revenue was $18.4 million in 2026.
drugdevelopment-technology.com is based in New York, New York.
The NAICS codes for drugdevelopment-technology.com are [32541, 3254, 325, 32].
The SIC codes for drugdevelopment-technology.com are [283, 28].